UC awarded 12th patent for CRISPR-Cas9 gene-editing technology

The Daily Californian writes, “The UC system and partners University of Vienna and Emmanuelle Charpentier were awarded a 12th patent for the CRISPR-Cas9 gene-editing technology from the U.S. Patent and Trademark Office, or USPTO, on Tuesday. CRISPR technology was developed by a team of researchers, including campus biochemistry and molecular biology professor Jennifer Doudna and former campus postdoctoral researcher Martin Jinek.”

Referencing client The University of California, Berkeley, Director Eldora L. Ellison, Ph.D. is quoted in the coverage saying, “The continued recognition from the USPTO of the Doudna-Charpentier team for the CRISPR-Cas9 gene-editing technology speaks to the revolutionary nature of the team’s work” and “The university remains committed to its fundamental mission of applying the CRISPR-Cas9 invention for the public good.”